Bernie Sanders Introduces Drug Importation Bill
Led by Senator Bernie Sanders, I-Vermont, Democrats introduced a new bill that would allow drugs from Canada to be imported to the United States. The Washington Post reported that the new bill would put increased pressure on pharmaceutical companies to bring down the price of drugs. During his campaign, President Donald Trump had expressed support for such an idea. Opponents of the law argue that it could result in patient harm if unsafe drugs make it into the United States.
Paul Ryan Has His Eye on Medicare Reform
While Trump promised not to make any cuts to Medicare, House Speaker Paul Ryan, R-Wisconsin, is singing a different tune. Ryan believes that the issue of Medicare is an open question and that the president only wants to keep benefits unchanged for people in or near retirement, according to CNN. Ryan believes that Medicare needs to be reformed in order to keep the program solvent.
Trump Derides FDA’s Process
During his joint address to Congress, the president called the FDA’s current drug approval process “slow and burdensome.” (To see more of his comments from the address, read our article.) STAT reported that Trump called on the FDA to speed up the approval of drugs for life-threatening diseases, and in the past he has called for eliminating regulations. As of yet, Trump has not nominated a commissioner to head the FDA.
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
HMO and EPO Insurance Plans More Likely to Promote Use of Biosimilars
November 21st 2023Health plan type highly influences the likelihood of biosimilar uptake, with low-flexibility insurance plans more likely to have patients who either switched to a biosimilar or were initiated on a biosimilar.
Read More
Oncology Onward: A Conversation With Dr Debra Patt of Texas Oncology
August 1st 2023Debra Patt, MD, PhD, MBA, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for episode 2 of our newest podcast, "Oncology Onward: Conversations With Innovators and Changemakers in Cancer Care."
Listen
Therapists’ Perspectives on Access to Telemental Health Among Medicaid-Enrolled Youth
November 10th 2023This qualitative study elucidates therapists’ perspectives on barriers to and facilitators of access to telemental health among Medicaid-enrolled youth served by a large safety-net organization.
Read More